Spiess PJ - Search Results

1

In vitro and in vivo antitumor properties of a T-cell clone generated from murine tumor-infiltrating lymphocytes.

Fox BA, Spiess PJ, Kasid A, Puri R, Mulé JJ, Weber JS, Rosenberg SA. Fox BA, et al. Among authors: spiess pj. J Biol Response Mod. 1990 Oct;9(5):499-511. J Biol Response Mod. 1990. PMID: 2174966

2

Identification of a T-cell receptor from a therapeutic murine T-cell clone.

Shilyansky J, Yang JC, Custer MC, Spiess P, Mixon A, Cole DJ, Mulé JJ, Rosenberg SA, Nishimura MI. Shilyansky J, et al. J Immunother. 1997 Jul;20(4):247-55. doi: 10.1097/00002371-199707000-00001. J Immunother. 1997. PMID: 9220314

3

A nonimmunogenic sarcoma transduced with the cDNA for interferon gamma elicits CD8+ T cells against the wild-type tumor: correlation with antigen presentation capability.

Restifo NP, Spiess PJ, Karp SE, Mulé JJ, Rosenberg SA. Restifo NP, et al. Among authors: spiess pj. J Exp Med. 1992 Jun 1;175(6):1423-31. doi: 10.1084/jem.175.6.1423. J Exp Med. 1992. PMID: 1588273 Free PMC article.

4

Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes.

Barth RJ Jr, Mulé JJ, Spiess PJ, Rosenberg SA. Barth RJ Jr, et al. Among authors: spiess pj. J Exp Med. 1991 Mar 1;173(3):647-58. doi: 10.1084/jem.173.3.647. J Exp Med. 1991. PMID: 1900079 Free PMC article.

5

Synergistic antitumor activity of tumor-infiltrating lymphocytes, interleukin 2, and local tumor irradiation. Studies on the mechanism of action.

Cameron RB, Spiess PJ, Rosenberg SA. Cameron RB, et al. Among authors: spiess pj. J Exp Med. 1990 Jan 1;171(1):249-63. doi: 10.1084/jem.171.1.249. J Exp Med. 1990. PMID: 2295878 Free PMC article.

6

Combination immunotherapy for cancer: synergistic antitumor interactions of interleukin-2, alfa interferon, and tumor-infiltrating lymphocytes.

Rosenberg SA, Schwarz SL, Spiess PJ. Rosenberg SA, et al. Among authors: spiess pj. J Natl Cancer Inst. 1988 Nov 2;80(17):1393-7. doi: 10.1093/jnci/80.17.1393. J Natl Cancer Inst. 1988. PMID: 3262772

7

In vivo antitumor activity of tumor-infiltrating lymphocytes expanded in recombinant interleukin-2.

Spiess PJ, Yang JC, Rosenberg SA. Spiess PJ, et al. J Natl Cancer Inst. 1987 Nov;79(5):1067-75. J Natl Cancer Inst. 1987. PMID: 3500355

8

Antitumor effects in mice of the intravenous injection of attenuated Salmonella typhimurium.

Rosenberg SA, Spiess PJ, Kleiner DE. Rosenberg SA, et al. Among authors: spiess pj. J Immunother. 2002 May-Jun;25(3):218-25. doi: 10.1097/01.CJI.0000014623.45316.93. J Immunother. 2002. PMID: 12000863 Free PMC article.

9

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes.

Rosenberg SA, Spiess P, Lafreniere R. Rosenberg SA, et al. Science. 1986 Sep 19;233(4770):1318-21. doi: 10.1126/science.3489291. Science. 1986. PMID: 3489291

10

Antigen-specific tumor vaccines. Development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy.

Zhai Y, Yang JC, Kawakami Y, Spiess P, Wadsworth SC, Cardoza LM, Couture LA, Smith AE, Rosenberg SA. Zhai Y, et al. J Immunol. 1996 Jan 15;156(2):700-10. J Immunol. 1996. PMID: 8543823

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters